CIK: 0001056807 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value ($000): $3,567,996 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 21,751,284 | $956,404 | 26.8% | $6.29 | +573.9% | CLASS A ORD | 61559X104 |
| RVMD | REVOLUTION MEDICINES INC | 5,981,212 | $232,131 | 6.5% | $25.19 | +48.4% | COM | 76155X100 |
| KYMR | KYMERA THERAPEUTICS INC | 5,161,801 | $154,080 | 4.3% | $32.15 | +7.7% | COM | 501575104 |
| IONS | IONIS PHARMACEUTICALS INC | 3,186,376 | $151,863 | 4.3% | $39.80 | +3.1% | COM | 462222100 |
| MIRM | MIRUM PHARMACEUTICALS INC | 4,370,024 | $149,411 | 4.2% | $27.38 | -4.3% | COM | 604749101 |
| GHRS | GH RESEARCH PLC | 10,400,158 | $121,266 | 3.4% | $18.98 | -36.8% | ORDINARY SHARES | G3855L106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 3,319,290 | $115,013 | 3.2% | $17.69 | +65.6% | COM | 74366E102 |
| CGEM | CULLINAN THERAPEUTICS INC | 5,750,683 | $100,292 | 2.8% | $20.31 | +4.9% | COM | 230031106 |
| OLMA | OLEMA PHARMACEUTICALS INC | 9,135,893 | $98,850 | 2.8% | $37.66 | -71.2% | COM | 68062P106 |
| GPCR | STRUCTURE THERAPEUTICS INC | 2,487,762 | $97,694 | 2.7% | $34.21 | — | SPONSORED ADS | 86366E106 |
| XOMA | XOMA CORP DEL | 3,633,743 | $86,083 | 2.4% | $15.57 | +60.6% | COM NEW | 98419J206 |
| KURA | KURA ONCOLOGY INC | 4,082,037 | $84,049 | 2.4% | $13.94 | +47.5% | COM | 50127T109 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 3,922,413 | $82,331 | 2.3% | $23.91 | +4.9% | COM | 35104E100 |
| AXSM | AXSOME THERAPEUTICS INC | 955,000 | $76,878 | 2.2% | $74.04 | 0.0% | COM | 05464T104 |
| CGON | CG ONCOLOGY INC | 2,417,885 | $76,333 | 2.1% | $39.48 | -12.2% | COM | 156944100 |
| — | MERUS N V | 1,279,049 | $75,681 | 2.1% | $30.94 | — | COM | N5749R100 |
| ACIU | AC IMMUNE SA | 18,834,936 | $75,151 | 2.1% | $4.56 | -27.5% | SHS | H00263105 |
| TYRA | TYRA BIOSCIENCES INC | 4,661,194 | $74,532 | 2.1% | $16.23 | +6.1% | COM | 90240B106 |
| — | 89BIO INC | 7,568,479 | $60,624 | 1.7% | $10.69 | — | COM | 282559103 |
| CELC | CELCUITY INC | 3,466,000 | $56,773 | 1.6% | $16.73 | 0.0% | COM | 15102K100 |
| — | THIRD HARMONIC BIO INC | 4,365,933 | $56,757 | 1.6% | $16.07 | — | COM | 88427A107 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1,190,107 | $51,317 | 1.4% | $36.09 | 0.0% | COM | 00847X104 |
| ZYME | ZYMEWORKS INC | 5,870,000 | $49,954 | 1.4% | $7.03 | +26.7% | COM | 98985Y108 |
| — | ESSA PHARMA INC | 8,748,629 | $46,018 | 1.3% | $3.65 | — | COM NEW | 29668H708 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,162,306 | $40,809 | 1.1% | $17.52 | +126.0% | COM | 45166A102 |
| GLPG | GALAPAGOS NV | 1,569,422 | $38,890 | 1.1% | $38.91 | — | SPON ADR | 36315X101 |
| ANNX | ANNEXON INC | 7,000,000 | $34,300 | 1.0% | $2.47 | +109.0% | COM | 03589W102 |
| — | REPARE THERAPEUTICS INC | 10,333,600 | $34,101 | 1.0% | $19.56 | — | COM | 760273102 |
| FHTX | FOGHORN THERAPEUTICS INC | 5,302,000 | $30,487 | 0.9% | $5.96 | 0.0% | COM | 344174107 |
| — | CALLIDITAS THERAPEUTICS AB | 750,000 | $29,243 | 0.8% | $23.30 | — | SPONSERED ADS | 13124Q106 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 1,521,948 | $29,237 | 0.8% | $9.95 | +101.6% | ORDINARY SHARES | N62509109 |
| ROIV | ROIVANT SCIENCES LTD | 2,742,409 | $28,987 | 0.8% | $11.31 | -3.1% | SHS | G76279101 |
| ENGN | ENGENE HOLDINGS INC | 2,251,037 | $21,227 | 0.6% | $10.40 | +23.4% | COM | 29286M105 |
| JANX | JANUX THERAPEUTICS INC | 441,528 | $18,496 | 0.5% | $15.21 | +208.7% | COM | 47103J105 |
| TCRX | TSCAN THERAPEUTICS INC | 2,989,474 | $17,488 | 0.5% | $2.68 | +194.0% | COM | 89854M101 |
| ELDN | ELEDON PHARMACEUTICALS INC | 6,293,282 | $16,614 | 0.5% | $4.95 | -51.8% | COM | 28617K101 |
| — | ALLAKOS INC | 16,552,417 | $16,552 | 0.5% | $3.39 | — | COM | 01671P100 |
| IMUX | IMMUNIC INC | 8,902,972 | $9,882 | 0.3% | $1.30 | -4.4% | COM | 4525EP101 |
| — | IKENA ONCOLOGY INC | 4,769,164 | $7,869 | 0.2% | $12.00 | — | COM | 45175G108 |
| — | VIGIL NEUROSCIENCE INC | 1,813,633 | $7,255 | 0.2% | $9.10 | — | COM | 92673K108 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,000,000 | $6,960 | 0.2% | $3.78 | +14.4% | COM | 92840H400 |
| CTMX | CYTOMX THERAPEUTICS INC | 5,228,461 | $6,379 | 0.2% | $5.34 | -62.7% | COM | 23284F105 |
| — | ELEVATION ONCOLOGY INC | 2,312,200 | $6,243 | 0.2% | $10.15 | — | COM | 28623U101 |
| VSTM | VERASTEM INC | 1,685,219 | $5,022 | 0.1% | $6.94 | +18.8% | COM NEW | 92337C203 |
| — | CIDARA THERAPEUTICS INC | 343,055 | $4,096 | 0.1% | $11.94 | — | COM NEW | 171757206 |
| — | VERVE THERAPEUTICS INC | 650,000 | $3,172 | 0.1% | $34.35 | — | COM | 92539P101 |
| MOLN | MOLECULAR PARTNERS AG | 443,221 | $3,169 | 0.1% | $19.71 | — | ADS | 60853G106 |
| OVID | OVID THERAPEUTICS INC | 3,853,818 | $2,964 | 0.1% | $4.24 | -34.4% | COM | 690469101 |
| SABS | SAB BIOTHERAPEUTICS INC | 917,826 | $2,845 | 0.1% | $5.51 | -33.4% | COM NEW | 78397T202 |
| — | GLYCOMIMETICS INC | 9,544,262 | $2,688 | 0.1% | $4.18 | — | COM | 38000Q102 |
| — | PIERIS PHARMACEUTICALS INC | 257,626 | $2,545 | 0.1% | $9.88 | — | COM NEW | 720795202 |
| IVA | INVENTIVA SA | 686,040 | $2,024 | 0.1% | $13.70 | — | ADS | 46124U107 |
| — | VIRACTA THERAPEUTICS INC | 3,614,662 | $1,965 | 0.1% | $8.50 | — | COM | 92765F108 |
| — | FORTE BIOSCIENCES INC | 2,982,105 | $1,601 | 0.0% | $0.66 | — | COM | 34962G109 |
| ENGNW | ENGENE HOLDINGS INC | 945,402 | $1,314 | 0.0% | $0.85 | — | *W EXP 10/31/202 | 29286M113 |
| — | NLS PHARMACEUTICS LTD | 5,747,126 | $1,247 | 0.0% | $1.29 | — | SHS | H57830103 |
| — | UNICYCIVE THERAPEUTICS INC | 2,200,000 | $1,102 | 0.0% | $1.08 | — | COM | 90466Y103 |
| RZLT | REZOLUTE INC | 190,815 | $821 | 0.0% | $19.25 | -82.2% | COM NEW | 76200L309 |
| — | MOLECULAR TEMPLATES INC | 522,238 | $601 | 0.0% | $6.32 | — | COM NEW | 608550208 |
| — | ASLAN PHARMACEUTICALS LTD | 1,049,999 | $315 | 0.0% | $3.65 | — | SPON ADS NEW | 04522R200 |